Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03745989 |
| Title | Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014) |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme Corp. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | CHE | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Florida Cancer Specialists ( Site 7000) | Sarasota | Florida | 34232 | United States | Details | |
| Next Oncology ( Site 0001) | San Antonio | Texas | 78229 | United States | Details | |
| BC Cancer-Vancouver Center ( Site 0011) | Vancouver | British Columbia | V5Z 4E6 | Canada | Details | |
| Princess Margaret Cancer Centre ( Site 0012) | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 0020) | Bellinzona | Ticino | 6500 | Switzerland | Details |